• Search History (Register)
  • MeSH Browser
  • [Clear]
    • English
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agency of Health Technology Assessment of Uruguay
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canada’s Drug Agency (CDA-AMC)
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Healthcare Quality Institute
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Regione Emilia Romagna
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [16733 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     National Institute for Health and Care Excellence (NICE) Mogamulizumab for previously treated mycosis fungoides and Sezary syndrome. NICE technology appraisal guidance 754
2021     National Institute for Health and Care Excellence (NICE) Risdiplam for treating spinal muscular atrophy. NICE technology appraisal guidance 755
2021     National Institute for Health and Care Excellence (NICE) Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis. NICE technology appraisal guidance 756
2021     Penn Medicine Center for Evidence-based Practice (CEP) Palliative care screening tools
2021     Penn Medicine Center for Evidence-based Practice (CEP) Procalcitonin for antimicrobial discontinuation in hospitalized adult patients
2021     Penn Medicine Center for Evidence-based Practice (CEP) Prone positioning of patients on extracorporeal membrane oxygenation (ECMO)
2021     Health Information and Quality Authority (HIQA) Duration of immunity (protection from reinfection) following SARS-CoV-2 infection
2021     NIHR Health Services and Delivery Research programme Hospital-based specialist palliative care compared with usual care for adults with advanced illness and their caregivers: a systematic review
2021     NIHR Health Technology Assessment programme Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model
2021     Penn Medicine Center for Evidence-based Practice (CEP) COVID-19: thrombotic adverse events with adenovirus vaccines
2021     NIHR Health Technology Assessment programme High-sensitivity troponin assays for early rule-out of acute myocardial infarction in people with acute chest pain: a systematic review and economic evaluation
2021     Austrian Institute for Health Technology Assessment (AIHTA) National strategies and programmes for preventing and managing non-communicable diseases in selected countries
2021     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with neoadjuvant chemotherapy for HER2-positive breast cancer and economic evaluation
2021     Penn Medicine Center for Evidence-based Practice (CEP) Tracheostomy or endotracheal tubes and subglottic suctioning
2021     Malaysian Health Technology Assessment (MaHTAS) Therapeutic drug monitoring (TDM) for anti-tuberculosis
2021     NIHR Health Technology Assessment programme Modelling tool to support decision-making in the NHS Health Check programme: workshops, systematic review and co-production with users
2021     Health Information and Quality Authority (HIQA) Review of international ethics frameworks used in policy-making in the context of screening
2021     Malaysian Health Technology Assessment (MaHTAS) Custodiol HTK as a replacement of blood cardioplegia in cardiac surgery
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Prevention of tuberculosis reactivation
2021     Malaysian Health Technology Assessment (MaHTAS) Mobile C-arm fluoroscopy for cardiothoracic surgery
2021     NIHR Health Technology Assessment programme Cognitive therapy compared with CBT for social anxiety disorder in adolescents: a feasibility study
2021     Penn Medicine Center for Evidence-based Practice (CEP) Opioids for vaso-occlusive crisis in pregnant patients
2021     NIHR Health Technology Assessment programme Improving continence in children and young people with neurodisability: a systematic review and survey
2021     Penn Medicine Center for Evidence-based Practice (CEP) COVID-19: vaccination for women who are pregnant or lactating
2021     Penn Medicine Center for Evidence-based Practice (CEP) COVID-19: management of vaccine-associated thrombotic syndromes
2021     Swiss Federal Office of Public Health (FOPH) Effectiveness and safety of vitamin B12 tests
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Yttrium-90 microspheres for intermediate- or advanced-stage hepatocellular carcinoma
2021     Malaysian Health Technology Assessment (MaHTAS) Viscoelastic haemostatic assay for non-cardiac surgery
2021     Health Information and Quality Authority (HIQA) The identification and review of new and updated public health guidance - COVID-19
2021     NIHR Health Technology Assessment programme CONservative TReatment of Appendicitis in Children a randomised controlled Trial CONTRACT (Feasibility study)
2021     Health Information and Quality Authority (HIQA) Duration of protective immunity following COVID-19 vaccination (efficacy and effectiveness)
2021     NIHR Health Services and Delivery Research programme Acute day units in non-residential settings for people in mental health crisis: the AD-CARE mixed-methods study
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Abiraterone acetate for metastatic castration-sensitive prostate cancer
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Remote monitoring programs for cardiac conditions
2021     Penn Medicine Center for Evidence-based Practice (CEP) COVID-19: effects of vaccines on fertility and pregnancy outcomes
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Bisphosphonate drugs for the treatment of osteoporosis in post-menopausal women
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Direct oral anticoagulants for atrial fibrillation [evidence update]
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Interventions to address and prevent violence toward health care workers in the emergency department
2021     Health Information and Quality Authority (HIQA) An international review: Policies relating to healthcare personnel who do not avail of COVID-19 vaccination
2021     NIHR Health Technology Assessment programme Understanding health-care outcomes of older people with cognitive impairment and/or dementia admitted to hospital: a mixed-methods study
2021     NIHR Health Technology Assessment programme Antidepressant medication to prevent depression relapse in primary care: the ANTLER RCT
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Amikacin (Mycobacterium avium complex pulmonary infections)]
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Hybrid closed-loop insulin delivery systems for people with Type 1 diabetes
2021     Health Technology Wales (HTW) Transcranial magnetic stimulation for the treatment of depression
2021     Health Information and Quality Authority (HIQA) Evidence synthesis for groups in vaccine allocation group nine - those aged 18-64 years living or working in crowded conditions
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Atidarsagen autotemcel (metachromatic leukodystrophy with biallelic mutation in the ARSA gene)]
2021     Health Information and Quality Authority (HIQA) Advice to the National Public Health Emergency Team: Derogation of healthcare workers, who are deemed close contacts, from restricted movements following COVID-19 vaccination
2021     NIHR Health Services and Delivery Research programme Models of generalist and specialist care in smaller acute hospitals: an exploratory study
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: noninvasive fetal RhD genotyping using maternal plasma]
2021     Scottish Health Technologies Group (SHTG) Detection of paroxysmal atrial fibrillation in patients with newly diagnosed ischaemic stroke
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Autologous anti-CD19-transduced CD3+ cells (mantle cell lymphoma, pretreated patients)]
2021     Health Information and Quality Authority (HIQA) Public health measures and strategies to limit the spread of COVID-19: an international review [Update]
2021     The Federal Joint Committee (G-BA) [Pharamceutical Directive/Annex XII: Avapritinib (gastrointestinal stromal tumours)]
2021     Health Information and Quality Authority (HIQA) Public health measures and strategies to limit the spread of COVID-19: an international review: Antigen testing in asymptomatic individuals in community settings
2021     Health Information and Quality Authority (HIQA) Current public health guidance for community settings and infection prevention and control measures in healthcare settings for COVID-19: a rapid review
2021     Canadian Agency for Drugs and Technologies in Health (CADTH) Stereotactic ablative radiotherapy for the treatment of oligometastatic cancer: a clinical review as part of a health technology assessment v1.0
2021     Swiss Federal Office of Public Health (FOPH) Statins in the primary prevention of cardiovascular events and mortality in Switzerland
2021     NIHR Health Technology Assessment programme Testing strategies for Lynch syndrome in people with endometrial cancer: systematic reviews and economic evaluation
2021     Swiss Federal Office of Public Health (FOPH) Vertebroplasty or kyphoplasty in painful osteoporotic vertebral compression fractures unresponsive to non-surgical treatment
2021     Swiss Federal Office of Public Health (FOPH) Chondroitin sulfate in osteoarthritis
2021     Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma, platele-rich fibrin (PRF) and concentrated growth factor (CGF) for treatment of periodontal disease
2021     NIHR Health Technology Assessment programme Paclitaxel-assisted balloon angioplasty of venous stenosis in haemodialysis access: PAVE RCT
2021     Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale (CIUSSS) [Identification of factors influencing the risk of absconding in a user with an intellectual disability, autism spectrum disorder or a mental health disorder]
2021     The Regional Health Technology Assessment Centre (HTA-centrum) Clinical effects of preoperative i.v. iron infusion in patients with colorectal cancer and iron-deficiency anemia
2021     The Regional Health Technology Assessment Centre (HTA-centrum) Clopidogrel versus ticagrelor as part of dual antiplatelet therapy for patients with acute coronary syndrome
2021     Penn Medicine Center for Evidence-based Practice (CEP) Venous irritation resulting from IV fosaprepitant
2021     The Regional Health Technology Assessment Centre (HTA-centrum) Efficacy and safety of endovascular versus surgical arteriovenous fistula creation for hemodialysis
2021     NIHR Health Technology Assessment programme Prospective randomised marker-based trial to assess the clinical utility and safety of biomarker-guided immunosuppression withdrawal in liver transplantation
2021     Penn Medicine Center for Evidence-based Practice (CEP) Oral hygiene interventions to prevent ventilator-associated pneumonia (VAP)
2021     The Regional Health Technology Assessment Centre (HTA-centrum) Effectiveness and safety of breast reduction surgery, compared with no surgery, in women with symptomatic breast hypertrophy
2021     Malaysian Health Technology Assessment (MaHTAS) Driving simulator in healthcare
2021     NIHR Health Technology Assessment programme Intratumoural immune signature to identify patients with primary colorectal cancer who do not require follow-up after resection: an observational study
2021     NIHR Health Technology Assessment programme Prognostic models of survival in patients with advanced incurable cancer: the PiPS2 observational study
2021     NIHR Health Technology Assessment programme Feasibility of a RCT of techniques for managing an impacted fetal head during emergency caesarean section: the MIDAS scoping study
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Cabozantinib (reassessment after the deadline: thyroid carcinoma)]
2021     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Brentuximab Vedotin (reassessment after the deadline: systemic anaplastic large cell lymphoma; first-line; combination with Cyclophosphamide, Doxorubicin, and Prednisone)]
2021     NIHR Health Technology Assessment programme Enzyme-linked immunosorbent assays for monitoring TNF-alpha inhibitors and antibody levels in people with rheumatoid arthritis: a systematic review and economic evaluation
2021     Malaysian Health Technology Assessment (MaHTAS) Delirium unit in geriatric ward
2021     NIHR Health Technology Assessment programme Fall prevention interventions in primary care to reduce fractures and falls in people aged 70 years and over: the PreFIT three-arm cluster RCT
2021     Malaysian Health Technology Assessment (MaHTAS) Digital assisted oral & cranio-maxillofacial surgery
2021     Malaysian Health Technology Assessment (MaHTAS) Platelet rich plasma (PRP), platelet-rich fibrin (PRF) and concentrated growth factor (CGF) for treatment of periodontal disease
2021     Norwegian Institute of Public Health (NIPH) Hydrogel rectal spacer SpaceOAR in prostate cancer radiation therapy - health economic evaluation
2021     NIHR Health Technology Assessment programme Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT
2021     Norwegian Institute of Public Health (NIPH) Transcatheter aortic valve implantation (TAVI) versus surgical aortic valve replacement (SAVR) for patients with severe aortic stenosis and low surgical risk and across surgical risk groups: a health technology assessment
2021     Malaysian Health Technology Assessment (MaHTAS) Proton beam therapy for the treatment of cancer - an update
2021     National Institute for Health and Care Excellence (NICE) Onasemnogene abeparvovec for treating spinal muscular atrophy. NICE highly specialised technologies guidance 15
2021     Scottish Health Technologies Group (SHTG) Minuteful Kidney for home testing of albumin-to-creatine ratio (ACR)
2021     NIHR Health Technology Assessment programme Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT
2021     Scottish Health Technologies Group (SHTG) Chest wall bracing for children and young people with pectus carinatum
2021     Agency for Healthcare Research and Quality (AHRQ) Automated-entry patient-generated health data for chronic conditions: the evidence on health outcomes
2021     Agency for Healthcare Research and Quality (AHRQ) Breast reconstruction after mastectomy
2021     Agency for Healthcare Research and Quality (AHRQ) Care coordination and care plans for transitions across care settings
2021     Agency for Healthcare Research and Quality (AHRQ) Cervical ripening in the outpatient setting
2021     National Institute for Health and Care Excellence (NICE) Givosiran for treating acute hepatic porphyria. NICE highly specialised technologies guidance 16
2021     National Institute for Health and Care Excellence (NICE) Metreleptin for treating lipodystrophy. NICE highly specialised technologies guidance 14
2021     Health Information and Quality Authority (HIQA) Systematic review of cost-effectiveness – management of chronic obstructive pulmonary disease in adults
2021     Austrian Institute for Health Technology Assessment (AIHTA) The economic and societal dimension of parental mental illness. Part 1: systematic review. Part II: economic evaluation framework
2021     Health Information and Quality Authority (HIQA) Budget impact analysis – management of chronic obstructive pulmonary disease in adults
2021     Austrian Institute for Health Technology Assessment (AIHTA) ≥ 12 month follow-up of patients with spinal muscular atrophy (SMA) treated with Spinraza®, Zolgensma® or combination therapies
2021     Agency for Healthcare Research and Quality (AHRQ) Disparities and barriers to pediatric cancer survivorship care